So, you are a hero and have decided to participate in a clinical trial. We all are deeply in your debt, so I want to start out and extend to you a very big thank you. Making that decision to participate in a clinical trial isn’t an easy decision for anyone. Participating in a trial [...]
Today the vast majority of us have access to a computer as well as the Internet. Thanks to powerful search engines we all have easy access to the world, including to an explosion of information about our health. The fact that you are reading this blog is the best example I could offer. However, in [...]
Malecare and the University of Minnesota are well on the way to making the Restore study, the largest and most comprehensive survey of gay and bisexual men with prostate cancer ever conducted. The Restore study is funded by the National Cancer Institute at NIH and is now recruiting men to complete their survey. You can [...]
For men with metastatic prostate cancer, understanding ones prostate specific antigen (PSA) kinetics is important. Despite the issues we hear surrounding the PSA, it is still the best measure you have in aiding you in the assessing your possible outcome prognosis. PSA kinetics also are a potential surrogate marker for clinical trial results. In most [...]
Teva Pharmaceutical Industries has received approval and launched, in the United States, a generic version of the Avodart (dutasteride) capsules at the 0.5 mg dose. Avodart, 5-alpha reductase inhibitor, is FDA approved for the treatment of men with benign prostate hyperplasia (an enlarged prostate gland), however, although not approved; men often use it as a [...]